At a Glance
+ND Capital Fund operates as a specialized venture capital firm targeting the intersection of life sciences, physical sciences, and data analytics since 2002. Based in New York, the firm has built a reputation for backing companies that apply computational approaches to traditional scientific problems, particularly in biotechnology and artificial intelligence applications for healthcare and materials science. With $800 million in assets under management, +ND Capital focuses primarily on seed-stage companies and later-stage Series B+ rounds, allowing them to both identify early breakthrough technologies and provide substantial growth capital to proven platforms. The firm's investment philosophy centers on supporting entrepreneurs who leverage advanced data science, machine learning, and computational biology to address fundamental challenges in drug discovery, diagnostics, agricultural technology, and materials innovation. Their portfolio approach emphasizes companies with strong intellectual property positions and defensible technology moats, particularly those that can demonstrate clear pathways to regulatory approval or commercial validation. +ND Capital has historically shown patience with longer development cycles inherent in life sciences investing, while simultaneously pursuing faster-moving AI and data science opportunities that can provide portfolio balance. The firm's deal sourcing benefits from deep relationships within academic research institutions and corporate R&D laboratories, particularly in the Northeast corridor. Their investment committee includes former pharmaceutical executives, computational biologists, and experienced technology entrepreneurs who can evaluate both the scientific merit and commercial viability of complex technical propositions. Over two decades of operation, +ND Capital has developed expertise in navigating regulatory pathways for biotech companies while also understanding the unique challenges of scaling AI-driven platforms in highly regulated industries. The firm typically leads or co-leads investment rounds, taking board positions and providing hands-on strategic guidance around clinical development, partnership strategies, and exit preparation.
“Invests in disruptive life, physical, and data sciences technologies.”
+ND Capital Fund's investment team combines scientific expertise with operational experience across biotechnology and technology sectors. The firm's partners typically bring backgrounds spanning computational biology, pharmaceutical development, and technology entrepreneurship, allowing them to evaluate both the technical merit and commercial potential of complex scientific propositions. Their team includes former executives from major pharmaceutical companies and successful technology startups, providing portfolio companies with access to industry networks and strategic guidance around clinical development, regulatory pathways, and partnership opportunities. The firm's collaborative approach leverages each partner's specialized knowledge to support entrepreneurs navigating the unique challenges of science-based startups.
+ND Capital Fund has raised multiple funds since its 2002 founding, growing its assets under management to $800 million through successive fundraising cycles. The firm's strategy has evolved to encompass both early-stage seed investments and larger Series B+ rounds, allowing them to support portfolio companies across extended development cycles typical of biotech and deep technology ventures. Their fund progression reflects increasing institutional investor confidence in their specialized approach to science-focused venture capital.
+ND Capital Fund primarily invests at the Seed, Series B+ stages. This means they focus on companies that are building their initial product and finding product-market fit.
+ND Capital Fund is headquartered in New York, NY. Many of their portfolio companies are also based in this region, though they invest across geographies.
+ND Capital Fund focuses on investments in Biotech, AI. Their portfolio reflects deep expertise and networks within these sectors.
+ND Capital Fund's typical investment check size ranges from $100K to $5M. Actual amounts may vary based on the stage, sector, and specific opportunity.
+ND Capital Fund manages approximately $800M in assets under management (AUM) across their funds.